Aurelia Tatic
Bucharest, B, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.
Journal: American journal of hematology
Published: July 29, 2024
Assessment of Total Antioxidant Capacity, 8-Hydroxy-2'-deoxy-guanosine, the Genetic Landscape, and Their Associations in BCR::ABL-1-Negative Chronic and Blast Phase Myeloproliferative Neoplasms.
Journal: International journal of molecular sciences
Published: May 23, 2024
Inflammatory profile of lower risk myelodysplastic syndromes.
Journal: British journal of haematology
Published: December 22, 2023
Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward.
Journal: Mycoses
Published: January 23, 2023
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective.
Journal: Haematologica
Published: September 21, 2020
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Journal: Haematologica
Published: November 19, 2018
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Journal: Haematologica
Published: November 19, 2018
Increased Dkk-1 plasma levels may discriminate disease subtypes in myeloproliferative neoplasms.
Journal: Journal of cellular and molecular medicine
Published: May 14, 2018
Last Updated: 09/26/2026